Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin, Ireland
SEC filing record 1 source field available
Fiscal year end
31 December
Nabriva Therapeutics plc has filed 695 SEC EDGAR filings since 14 May 2015

SEC filing history

Showing 651-675 of 695 matching filings.

Per page
25
Current page
27
SC 13G File 005-89113

SC 13G filing

Filing date
29 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
20-F File 001-37558

20-F

Filing date
28 Apr 2016
Reporting date
31 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37558

6-K

Filing date
08 Apr 2016
Reporting date
08 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89113

SEC SCHEDULE 13G

Filing date
23 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89113

SCHEDULE 13G

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89113

PHASE4 PARTNERS LTD SC 13G 9-23-2015 (NABRIVA THERAPEUTICS)

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37558

6-K

Filing date
11 Jan 2016
Reporting date
11 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37558

6-K

Filing date
30 Dec 2015
Reporting date
30 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-208097

S-8

Filing date
18 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37558

6-K

Filing date
10 Nov 2015
Reporting date
11 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89113

SC 13G

Filing date
05 Oct 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-89113

SCHEDULE 13D

Filing date
02 Oct 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-37558

FORM 6-K

Filing date
30 Sep 2015
Reporting date
30 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89113

SCHEDULE 13G

Filing date
29 Sep 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89113

SCHEDULE 13G

Filing date
25 Sep 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-6 POS File 333-206771

POST EFFECTIVE AMENDMENT NO. 1 TO THE FORM F-6

Filing date
21 Sep 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-205073

424B4

Filing date
21 Sep 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-205073

FREE WRITING PROSPECTUS

Filing date
18 Sep 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-206771

EFFECT filing

Filing date
17 Sep 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-205073

EFFECT filing

Filing date
17 Sep 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
17 Sep 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-1/A File 333-205073

FORM F-1 (AMENDMENT NO. 4)

Filing date
17 Sep 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .